Does Bristol Myers Squibb offer co-pay assistance for federal healthcare patients?
Patients insured through Federal Healthcare Programs are not eligible for co-pay assistance programs sponsored by Bristol Myers Squibb. BMS Access Support can make a referral to independent charitable foundations offering support for your specific patient. Please contact BMS Access Support at 1-800-861-0048 for details.
How can I get help with the cost of Opdivo?
Help patients find transportation, medical services, care at home, and other local healthcare-related resources. BMS Access Support ® can help identify financial assistance programs for eligible patients who have been prescribed OPDIVO and who need help managing the cost of treatment. The appropriate program will depend on the patient's coverage.
How do I contact BMS access support?
Please contact BMS Access Support at 1-800-861-0048 for details. For patients without prescription drug insurance or for patients who are underinsured, BMS Access Support can make a referral to independent charitable foundations that may be able to help.
Do you have a complaint about a Bristol Myers Squibb product?
If you, or someone you know, have possibly experienced a side effect or have a product complaint while taking a Bristol Myers Squibb product, please contact us. As of 2019, Bristol Myers Squibb and Celgene have merged.
See more
Does Bristol-Myers have a patient assistance program?
Bristol-Myers Squibb Company (BMS) established the Bristol-Myers Squibb Patient Assistance Foundation, Inc. (BMSPAF) to help patients who need help paying for medicines prescribed by their healthcare providers.
How do you qualify for free eliquis?
You may be eligible for the Free 30-Day Trial Offer for ELIQUIS® (apixaban) if:You have not previously filled a prescription for ELIQUIS;You have a valid 30-day prescription for ELIQUIS;You are being treated with ELIQUIS for an FDA-approved indication that an HCP has planned for more than 35 days of treatment;More items...
What pharmaceutical Company manufactures eliquis?
Brand Name: Eliquis® Generic Name: apixaban Manufacturer: Bristol-Myers Squibb Co.
What do I do if I can't afford Eliquis?
Call Tap to call 1-855-ELIQUIS (354-7847) from Monday – Friday, 8 AM – 8 PM (ET). Live specialists are here to: Help you find out if ELIQUIS is covered by your insurance plan. Determine if you are eligible for assistance paying for ELIQUIS.
How much does Eliquis cost at Walmart?
The cost of Eliquis is $695.91 for 60, 5MG Tablet, but you can use an Eliquis coupon below to pay $459.24 per 60, 5mg Tablet....Average 12 Month Prices for Eliquis.PharmacyEliquis Retail PriceEliquis SingleCare PriceWalmart$601.08$528.01Walgreens$623.72$537.78Kroger Pharmacy$624.91$487.613 more rows
Why is Eliquis being recalled?
Eliquis was recalled on June 10th, 2017, due to a possible packaging error. It was found that a bottle labeled as Eliquis 5 mg contained 2.5 mg tablets, a lower strength. Receiving the wrong strength of Eliquis could potentially cause severe adverse effects like a blood clot, stroke, or death.
Is there a lawsuit against Eliquis?
More than 130 lawsuits have been filed against Bristol-Myers Squibb and Pfizer over alleged injuries and deaths caused by Eliquis. Plaintiffs in Eliquis lawsuits make a number of accusations against the drugmakers, including the following: Not providing adequate warnings about Eliquis' lack of a bleeding reversal agent.
Which is safer Xarelto or Eliquis?
A review and meta-analysis of Eliquis and Xarelto for acute venous thromboembolism (VTE) concluded that both drugs were similarly effective but that Eliquis may be safer. The patients treated with Xarelto experienced more bleeding—both major and minor.
How do seniors pay for Eliquis?
Medicare typically covers Eliquis through Medicare Advantage Part C or Medicare Part D prescription drug coverage plans. Eliquis is a brand name for apixaban, a prescription oral anticoagulant tablet.
What is the cost of a 30-day supply of Eliquis?
This information is intended to help you understand the costs of ELIQUIS. The list price for a 30-day supply of ELIQUIS is $529. On average, patients pay $46 per month, and 5 out of 10 ELIQUIS patients pay $25 or less. Co-pay Card information.
How much is a 60 day supply of Eliquis?
The cost for Eliquis oral tablet 5 mg is around $567 for a supply of 60 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.
When will a generic for Eliquis be available?
Based on settlement agreements reached with other generic manufacturers, we currently expect generic entry could occur after 2026 but before 2031, subject to appeals and future challenges,” BMS said in a statement. The two companies entered into a collaboration agreement for Eliquis generic in 2007.
What is BMSPAF in medical terms?from bmspaf.org
The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website.
Who must contact the company for refills?from rxassist.org
The patient or doctor must contact the company for refills.
What is the Patient Advocate Foundation?from patientadvocate.org
Patient Advocate Foundation (PAF) stands in solidarity with the Asian American and Pacific Islander (AAPI) community and denounces violence and racism against all communities of color. As advocates, our mission… ...Read More
How to fill out and sign BSA online?from uslegalforms.com
Get your online template and fill it in using progressive features. Enjoy smart fillable fields and interactivity. Follow the simple instructions below:
What is the mission of Bristol Myers Squibb?from news.bms.com
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook and Instagram.
What is opdivo used for?from opdivo.com
OPDIVO ® (nivolumab) is a prescription medicine used to treat people with cancer of the stomach (gastric), cancer where the esophagus joins the stomach (gastroesophageal junction), and in people with esophageal adenocarcinoma. OPDIVO may be used in combination with chemotherapy that contains fluoropyrimidine and platinum when your cancer cannot be ...
What are the adverse reactions of opdivo?from news.bms.com
Severe or fatal cases have been reported for some of these adverse reactions: cardiac/vascular: myocarditis, pericarditis, vasculitis; nervous system: meningitis, encephalitis, myelitis and demyelination, myasthenic syndrome/myasthenia gravis (including exacerbation), Guillain-Barré syndrome, nerve paresis, autoimmune neuropathy; ocular: uveitis, iritis, and other ocular inflammatory toxicities can occur; gastrointestinal: pancreatitis to include increases in serum amylase and lipase levels, gastritis, duodenitis; musculoskeletal and connective tissue: myositis/polymyositis, rhabdomyolysis, and associated sequelae including renal failure, arthritis, polymyalgia rheumatica; endocrine: hypoparathyroidism; other (hematologic/immune): hemolytic anemia, aplastic anemia, hemophagocytic lymphohistiocytosis (HLH), systemic inflammatory response syndrome, histiocytic necrotizing lymphadenitis (Kikuchi lymphadenitis), sarcoidosis, immune thrombocytopenic purpura, solid organ transplant rejection.
What is Opdivo clinical development?from news.bms.com
Opdivo’s leading global development program is based on Bristol Myers Squibb’s scientific expertise in the field of Immuno-Oncology, and includes a broad range of clinical trials across all phases, including Phase 3, in a variety of tumor types. To date, the Opdivo clinical development program has treated more than 35,000 patients. The Opdivo trials have contributed to gaining a deeper understanding of the potential role of biomarkers in patient care, particularly regarding how patients may benefit from Opdivo across the continuum of PD-L1 expression.
What are the primary endpoints of the Opdivo trial?from news.bms.com
The primary endpoints of the trial are overall survival (OS) and progression-free survival (PFS) by blinded independent central review (BICR) in patients whose tumors express PD-L1, for both Opdivo-based combinations versus chemotherapy. Secondary endpoints of the trial include overall survival and progression-free survival by BICR in the all-randomized population.
What is BMS access support?from bmsaccesssupport.bmscustomerconnect.com
BMS Access Support ® is focused on your patients’ access needs 1 Benefits Review, prior authorization, and appeals assistance 2 Easy-to-initiate co-pay assistance process and information on financial support 3 Support from Care Coordinators, assigned by region, and local Access and Reimbursement Managers
Can opdivo cause fetal harm?from news.bms.com
Based on its mechanism of action and findings from animal studies, OPDIVO and YERVOY can cause fetal harm when administered to a pregnant woman. The effects of YERVOY are likely to be greater during the second and third trimesters of pregnancy. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with OPDIVO and YERVOY and for at least 5 months after the last dose.
What is BMS Access Support?
BMS Access Support ® can help identify financial assistance programs for eligible patients who have been prescribed OPDIVO and who need help managing the cost of treatment. The appropriate program will depend on the patient's coverage.
What is BMSPAF in medical terms?
The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF), a charitable organization, may also provide medicine, free of charge, to eligible, uninsured patients who have an established financial hardship.
Does Bristol Myers Squibb guarantee reimbursement?
Bristol Myers Squibb cannot guarantee that a patient will receive assistance. The accurate completion of reimbursement- or coverage-related documentation is the responsibility of the healthcare provider and patient. Bristol Myers Squibb and its agents make no guarantee regarding reimbursement for any service or item.
How to fill out and sign eliquis patient assistance program bristol myers squibb online?from uslegalforms.com
Get your online template and fill it in using progressive features. Enjoy smart fillable fields and interactivity. Follow the simple instructions below:
What is BMSPAF in medical terms?from bmspaf.org
The Bristol Myers Squibb Patient Assistance Foundation (BMSPAF) is an independent, charitable organization that helps eligible patients who need temporary help obtaining the medicines listed on this website.
Does Bristol Myers Squibb charge for delivery?from bmspaf.org
Check your eligibility. The Bristol Myers Squibb Patient Assistance Foundation does not charge any application, participation, or delivery fees.
What is OPDIVO used for?
OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT). OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment ...
What is OPDIVO in combination with?
OPDIVO, in combination with YERVOY ® (ipilimumab), is indicated for the treatment of patients with unresectable or metastatic melanoma.
What is odivo in cancer?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the treatment of adults and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What is opdivo nivolumab?
OPDIVO ® (nivolumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
What is the name of the drug that is used to treat pleural mesothelioma?
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma (MPM).
Does opdivo cause liver toxicity?
OPDIVO in combination with cabozantinib can cause hepatic toxicity with higher frequencies of Grade 3 and 4 ALT and AST elevations compared to OPDIVO alone. Consider more frequent monitoring of liver enzymes as compared to when the drugs are administered as single agents. In patients receiving OPDIVO and cabozantinib, Grades 3 and 4 increased ALT or AST were seen in 11% of patients.
Is opdivo a single agent?
OPDIVO ® (nivolumab), as a single agent, is indicated for the treatment of adult and pediatric (12 years and older) patients with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What is OPDIVO used for?from opdivohcp.com
OPDIVO is indicated for the adjuvant treatment of completely resected esophageal or gastroesophageal junction cancer with residual pathologic disease in patients who have received neoadjuvant chemoradiotherapy (CRT). OPDIVO, in combination with fluoropyrimidine- and platinum-containing chemotherapy, is indicated for the treatment ...
What is opdivo nivolumab?from opdivohcp.com
OPDIVO ® (nivolumab) is indicated for the treatment of patients with locally advanced or metastatic urothelial carcinoma who have disease progression during or following platinum-containing chemotherapy or have disease progression within 12 months of neoadjuvant or adjuvant treatment with platinum-containing chemotherapy.
What is odivo in cancer?from opdivohcp.com
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the treatment of adults and pediatric patients 12 years and older with microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (CRC) that has progressed following treatment with a fluoropyrimidine, oxaliplatin, and irinotecan. This indication is approved under accelerated approval based on overall response rate and duration of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in confirmatory trials.
What is the name of the drug that is used to treat pleural mesothelioma?from opdivohcp.com
OPDIVO ® (nivolumab), in combination with YERVOY ® (ipilimumab), is indicated for the first-line treatment of adult patients with unresectable malignant pleural mesothelioma (MPM).
What is BMS Access Support?from bmsaccesssupport.bmscustomerconnect.com
BMS Access Support ® can help identify financial assistance programs for eligible patients who have been prescribed OPDIVO and who need help managing the cost of treatment. The appropriate program will depend on the patient's coverage.
Can opdivo cause fetal harm?from opdivohcp.com
Based on its mechanism of action and findings from animal studies, OPDIVO and YERVOY can cause fetal harm when administered to a pregnant woman. The effects of YERVOY are likely to be greater during the second and third trimesters of pregnancy. Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective contraception during treatment with OPDIVO and YERVOY and for at least 5 months after the last dose.
Can OPDivo cause thyroid problems?from opdivohcp.com
OPDIVO and YERVOY can cause primary or secondary adrenal insufficiency, immune-mediated hypophysitis, immune-mediated thyroid disorders, and Type 1 diabetes mellitus, which can present with diabetic ketoacidosis. Withhold OPDIVO and YERVOY depending on severity (please see section 2 Dosage and Administration in the accompanying Full Prescribing Information). For Grade 2 or higher adrenal insufficiency, initiate symptomatic treatment, including hormone replacement as clinically indicated. Hypophysitis can present with acute symptoms associated with mass effect such as headache, photophobia, or visual field defects. Hypophysitis can cause hypopituitarism; initiate hormone replacement as clinically indicated. Thyroiditis can present with or without endocrinopathy. Hypothyroidism can follow hyperthyroidism; initiate hormone replacement or medical management as clinically indicated. Monitor patients for hyperglycemia or other signs and symptoms of diabetes; initiate treatment with insulin as clinically indicated.
What is the number to call for Bristol Myers Squibb?
For more information about how insurance covers SPRYCEL and co-pay assistance for eligible, commercially-insured patients, visit Bristol Myers Squibb Access Support or call 1-800-861-0048. Assistance for Uninsured Patients.
What is the number to call for emollicipi?
For more information about how insurance covers EMPLICITI and co-pay assistance for eligible, commercially-insured patients, visit BMS Access Support or call 844-367-5424.
What is the number to call for Reblozyl?
For more information about how insurance covers REBLOZYL and co-pay assistance for eligible, commercially-insured patients, visit Bristol Myers Squibb Access Support or call 1-800-861-0048. Assistance for Uninsured Patients.
Does insurance pay for Bristol Myers Squibb?
Some Bristol Myers Squibb medications are available free of charge. If you are struggling to make ends meet financially, do not have insurance that pays for your Bristol Myers Squibb medication, and meet other requirements, we may be able to help. If you, or someone you know, have possibly experienced a side effect or have a product complaint ...
Is Bristol Myers Squibb merged with Celgene?
As of 2019, Bristol Myers Squibb and Celgene have merged. If you or someone you know have possibly experienced a side effect or have a product complaint while taking a legacy Celgene product, please contact us. 1-800-640-7854. (toll free U.S. only) Bristol Myers Squibb COVID-19 Response Line. 1-800-721-8909.